Showing results (171-180 of 432) with videos related to

Sort By:
Pageof 44
Antimicrobial Agents and Chemotherapy|August 3, 2011
Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factorsEzequiel Ruiz-Mateos, Alejandro González-Serna, Miguel Genebat, et al.
Journal of Hepatology|November 3, 2004
Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver diseaseFrancesc Vidal, Alfons Lorenzo, Teresa Auguet, et al.
American Journal of Infection Control|June 3, 2009
Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolatesMiguel López-Dupla, José-Antonio Martínez, Francesc Vidal, et al.
Plos One|September 7, 2012
Model to track wild birds for avian influenza by means of population dynamics and surveillance informationAnna Alba, Dominique J Bicout, Francesc Vidal, et al.
Antiviral Research|May 25, 2016
Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokinesRicardo Moure, Pere Domingo, José M Gallego-Escuredo, et al.
Biomed Research International|August 30, 2014
Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patientsPatricia Echeverría, Pere Domingo, Josep-María Llibre, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 15, 2025
Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in SpainAnna Camps-Vilaró, Ramon Teira, Isaac Subirana, et al.
AIDS (London, England)|June 23, 2006
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovirJosep M Llibre, Pere Domingo, Rosario Palacios, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2015
Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levelsEugènia Negredo, Adolfo Diez-Pérez, Anna Bonjoch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavirEsteban Martínez, Pere Domingo, María J Galindo, et al.
Pageof 44